In the past several months, the drug Risperdal has been the subject of a massive $2.2 billion fine from the Department of Justice for false marketing, as well as hundreds of lawsuits from families alleging their children developed abnormal breast growth and lactation.
Recent studies have shown that the progestin hormone drospirenone, used in birth control pills like Yaz and Yasmin, may increase risks of blood clots by as much as 74%.
For the past year, lawyers have been helping those who suffered internal bleeding while taking Pradaxa file lawsuits in a special federal multi district litigation court.
Merck’s NuvaRing contraceptive insert was approved by the FDA in 2001 and launched in the United States in 2002. In the decade since, it has been used by millions of women and is now available in 32 countries.
Following recent warnings by the FDA that the antiepileptic drug Topamax may significantly increase the risk of certain birth defects, hundreds of families have filed lawsuits over their child’s injuries and the failure of Johnson & Johnson to give warning.
Amid troubling reports that Johnson & Johnson may have fraudulently marketed its antipsychotic drug Risperdal for use in children, studies now show those children may face harmful side effects.
In 2010, Johnson & Johnson initiated one of the largest medical device recalls in history when it recalled its DePuy ASR hip implants used in over 93,000 patients.
By now, most people have seen one of the many TV commercials advising those women who suffered blood clots after taking Yaz or Yasmin that they may qualify for compensation. The good news is, this is true for many patients.
For over a year, DrugRisk has tracked safety concerns over the popular anticoagulant drug Pradaxa. Numerous health agencies have warned that the medication can cause internal bleeding problems at a greater rate than traditional blood thinners like warfarin.
DrugRisk has learned of a new development in the NuvaRing blood clot litigation that could mean a settlement for victims in the near future. A judge overseeing lawsuits recently delayed the start of the first trial and asked lawyers to give an updated count of cases.